MEC Global Events
cordially invites participants from all over the world to premier Global Meeting
on Cancer scheduled during November 13-14, 2020 Virtual Conference which
includes major keynote presentations, plenary talks and poster presentation. Cancer
2020 is designed to gather the experts in the field of oncology and related
areas.
Cancer
2020 will be focused mainly on the theme: Exploring the Research
Advancements in Cancer and its therapy.
Cancer 2020 is the best opportunity
for all the oncology and cancer related doctors, oncology professionals,
scientists, Radiologists, oncology professionals, surgeons, Physicians,
research scholars, students who are working in oncology and its allied areas to
explore their scientific research across the globe.
Cancer Genetics & Genomics
Cancer Immunotherapy & Vaccines
Cancer Metabolism
Breast Cancer
Skin Cancer
Brain Cancer
Prostate cancer
Oncology and Computational Oncology
Epigenetics
Cancer Immunology
Cell Signaling & Regulation
Metastasis & Drug Resistance
Stem Cells for Cancer
Oncologists
Haematologists
Research scholars
Students and Young Researchers
Relevant Association and Societies
Business professionals across the
globe
Pathologists
Corporate Cancer Research Professional
Software Developing Companies
Radiologists
Chemotherapists
Market Report
The global cancer therapy market is
estimated to grow with a CAGR of 8.37% during the forecasted period. Certain
factors that are driving the market growth include increasing Patient
Assistance Programs (PAPs), increasing government initiatives for cancer
awareness, rising prevalence of cancer worldwide, and strong R&D
initiatives from key players.
More than 45 million Americans do not
have health insurance and millions more are underinsured; eight out of 10
uninsured people are from working families. Among those with health insurance,
one out of 10 individuals, 65 years old or younger, and one in three persons
over 65 years do not have prescription drug coverage. Hence, Patients
Assistance Programs (PAPs) have emerged in an effort to help patients who are
lacking health insurance or prescription drug coverage get the medication they need. These programs
are provided by pharmaceutical companies to provide free or low-cost
prescription drugs to patients who are suffering from serious illnesses.
Amgen Inc.
AstraZeneca PLC
Bayer AG
Johnson and Johnson
Merck & Co. Inc